2022 Nuclear Medicine & Molecular Imaging News

The Radiological Society of North America awarded Ophir Vermesh, MD, PhD, a Research & Education Foundation Grant at its annual meeting held on November 27 - December 1, 2022, in Chicago. This R&E Foundation grant gives young radiologists the chance to gain insight and experience in scientific investigation while they’re still in training.

At the Western Region Society of Nuclear Medicine (WRSNM) Annual Meeting held on October 28 - 30, in Lake Tahoe, Dr. Vermesh received an In-Training Physician Scientist Award.

The Academy for Radiology & Biomedical Imaging Research selected Andrei Iagaru, MD, Professor of Radiology and Division Chief of Nuclear Medicine and Molecular Imaging, to the Academy Council of Distinguished Investigators (DI's) Class of 2022. One of the Academy's highest accolades, this prestigious honor recognizes individuals for their outstanding contributions to the field of medical imaging. Dr. Iagaru’s research interests include PET/MRI and PET/CT for early cancer detection; clinical translation of novel PET radiopharmaceuticals; peptide-based diagnostic imaging and therapy; targeted radionuclide therapy.

Dr. Iagaru is one of only 40 researchers selected to receive the Academy’s 2022 Distinguished Investigator Award. He will be honored for achievement at this year's annual Academy Gold Medal and Distinguished Investigator ceremony and reception held during the 2022 RSNA in Chicago, IL on Tuesday, November 29, 2022, from 3-5PM CT in McCormick Place Convention Center.

“These Distinguished Investigators represent the future of imaging, advancing the field overall as well as developing ways to significantly improve patient care through their research efforts.” said Elizabeth A. Krupinski, PhD, Council of Distinguished Investigators Co-Chair.

Dr. Iagaru will be honored for achievement at this year's annual Academy Gold Medal and Distinguished Investigator ceremony and reception help during the 2022 RSNA in Chicago, IL on Tuesday, November 29, 2022, from 3-5PM CT in McCormick Place Convention Center.

"A big round of applause for David Kersting, the winner of the EANM Sanjiv Gambhir Young Investigator Award! It was a close battle between the six nominees, ending up in a tie between David Kersting and Sophie E. M. Veldhuijzen van Zanten. So a Golden Buzzer question had to decide and David was the faster one. So congratulations to all participants and thanks to the jury, the sponsor and the audience who made this session truly memorable. David, we wish you a great time at Stanford University!"

Kindly Supported by Telix Pharmaceuticals

"The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has named Stanford Health Care and the Dana-Farber Brigham Cancer Center as its first two designated Radiopharmaceutical Therapy Centers of Excellence. The institutions are designated as comprehensive centers that administer multiple radiopharmaceutical therapies — such as those to treat thyroid cancer, prostate cancer and neuroendocrine tumors—and activelyengage in radiopharmaceutical therapy research.

SNMMI created the Radiopharmaceutical Therapy Center of Excellence program to certify sites that meet strict regulatory, training, qualification, experience and performance criteria for radiopharmaceutical therapy. With the Radiopharmaceutical Therapy Centers of Excellence designation, institutions can assure patients, their families, referring physicians and payors that rigorous procedures are in place and followed, ultimately leading to appropriate patient selection and optimal outcomes from radiopharmaceutical therapy."